Heart Failure-Induced Skeletal Muscle Wasting

Area of Science:

• Cardiology
• Exercise Physiology
• Skeletal Muscle Biology

Background:

• Heart failure (HF) is a condition where the heart cannot pump enough oxygenated blood to meet the body's needs.
• HF can lead to cardiac cachexia, characterized by generalized wasting of skeletal muscle, fat, and bone.
• Patients with HF often experience dyspnea, fatigue, and reduced exercise tolerance.

Purpose of the Study:

• To review the phenotypic characteristics of skeletal myopathy induced by heart failure.
• To explore the mechanisms underlying muscle wasting in HF patients.
• To highlight potential therapeutic strategies for skeletal muscle wasting in HF.

Main Methods:

• This review synthesizes current research on HF-induced skeletal myopathy.
• It examines the structural, metabolic, and functional changes in skeletal muscle.
• Mechanisms of muscle wasting and therapeutic interventions are discussed.

Main Results:

• Impaired exercise capacity in HF is due to abnormal muscle metabolism, apoptosis, and atrophy, not just reduced blood flow.
• Skeletal muscle abnormalities include altered energy metabolism, mitochondrial dysfunction, myofiber type transition, and reduced strength.
• Exercise training is the only intervention demonstrated to improve skeletal muscle metabolism, growth factor activity, and functional capacity, reversing peripheral abnormalities.

Conclusions:

• Skeletal muscle wasting and exercise intolerance in HF are complex issues driven by metabolic and structural changes.
• Exercise training offers a promising therapeutic approach to counteract skeletal muscle abnormalities in HF.
• Further research into targeted therapies could improve outcomes for HF patients experiencing muscle wasting.